The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population
Objective Mutations of TP53 as a tumor suppressor gene are frequently observed in different types of cancer. A codon 72 polymorphism located on exon 4 with two alleles encoding either Proline (CCC) or Arginine (CGC) has been indicated as a common variation in association with cancers. Controversial...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Royan Institute (ACECR), Tehran
2020-07-01
|
| Series: | Cell Journal |
| Subjects: | |
| Online Access: | https://celljournal.org/journal/article/fulltext/the-dilemma-of-tp53-codon-72-polymorphism-rs1042522-and-breast-cancer-risk-a-case-control-study-and-meta-analysis-in-iranian-population.pdf |
| _version_ | 1819170421481668608 |
|---|---|
| author | Fahimeh Afzaljavan Negin Chaeichi Tehrani Mahdi Rivandi Saeed Zarif Ghasemian Elham Vahednia Reza Khayami Mohammad Abavisani Alireza Pasdar |
| author_facet | Fahimeh Afzaljavan Negin Chaeichi Tehrani Mahdi Rivandi Saeed Zarif Ghasemian Elham Vahednia Reza Khayami Mohammad Abavisani Alireza Pasdar |
| author_sort | Fahimeh Afzaljavan |
| collection | DOAJ |
| description | Objective
Mutations of TP53 as a tumor suppressor gene are frequently observed in different types of cancer. A codon 72 polymorphism located on exon 4 with two alleles encoding either Proline (CCC) or Arginine (CGC) has been indicated as a common variation in association with cancers. Controversial results have been reported regarding the association of allelic polymorphism of codon 72 of TP53 gene and breast cancer risk in Iranian patients. Therefore, a case-control study was designed. A meta-analysis was also carried out to provide evidence of association between this variation and breast cancer in Iran, based on all available published data.
Materials And Methods
In this case-control study, blood sample of 622 participants, including 308 breast cancer cases and 314 controls were collected. Genotyping for rs1042522 was conducted by Allele Specific polymerase chain reaction (AS-PCR). In order to set a meta-analysis study, PubMed, Scopus and ISI Web of Knowledge and Persian databases were searched to explore relevant studies, published up to September 2018, containing information on TP53 polymorphism and the risk of breast cancer in Iran. Statistical analysis was performed using SPSS 16.0 and MetaGenyo.
Results
All retrieved available data as well as the results of our current study were consisted of 1965 breast cancer cases and 1999 healthy controls. No significant difference was observed in allele frequencies between groups (P=0.90) in our study. The cumulative results did not also show any association between rs1042522 and breast cancer risk on the dominant (P=0.61) and recessive (P=0.89) models.
Conclusion
These findings cannot support contribution of rs1042522 polymorphism to breast cancer risk in an Iranian population. Future larger studies may help confirm this finding with a greater power. |
| first_indexed | 2024-12-22T19:35:08Z |
| format | Article |
| id | doaj.art-3652e2753b9649e39d2ab9d7e632a040 |
| institution | Directory Open Access Journal |
| issn | 2228-5806 2228-5814 |
| language | English |
| last_indexed | 2024-12-22T19:35:08Z |
| publishDate | 2020-07-01 |
| publisher | Royan Institute (ACECR), Tehran |
| record_format | Article |
| series | Cell Journal |
| spelling | doaj.art-3652e2753b9649e39d2ab9d7e632a0402022-12-21T18:15:00ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142020-07-0122218519210.22074/cellj.2020.6458The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian PopulationFahimeh Afzaljavan0Negin Chaeichi Tehrani1Mahdi Rivandi2Saeed Zarif Ghasemian3Elham Vahednia4Reza Khayami5Mohammad Abavisani6Alireza Pasdar7Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, IranDepartment of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, IranDepartment of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, IranStudent Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, IranDepartment of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, IranStudent Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, IranObjective Mutations of TP53 as a tumor suppressor gene are frequently observed in different types of cancer. A codon 72 polymorphism located on exon 4 with two alleles encoding either Proline (CCC) or Arginine (CGC) has been indicated as a common variation in association with cancers. Controversial results have been reported regarding the association of allelic polymorphism of codon 72 of TP53 gene and breast cancer risk in Iranian patients. Therefore, a case-control study was designed. A meta-analysis was also carried out to provide evidence of association between this variation and breast cancer in Iran, based on all available published data. Materials And Methods In this case-control study, blood sample of 622 participants, including 308 breast cancer cases and 314 controls were collected. Genotyping for rs1042522 was conducted by Allele Specific polymerase chain reaction (AS-PCR). In order to set a meta-analysis study, PubMed, Scopus and ISI Web of Knowledge and Persian databases were searched to explore relevant studies, published up to September 2018, containing information on TP53 polymorphism and the risk of breast cancer in Iran. Statistical analysis was performed using SPSS 16.0 and MetaGenyo. Results All retrieved available data as well as the results of our current study were consisted of 1965 breast cancer cases and 1999 healthy controls. No significant difference was observed in allele frequencies between groups (P=0.90) in our study. The cumulative results did not also show any association between rs1042522 and breast cancer risk on the dominant (P=0.61) and recessive (P=0.89) models. Conclusion These findings cannot support contribution of rs1042522 polymorphism to breast cancer risk in an Iranian population. Future larger studies may help confirm this finding with a greater power.https://celljournal.org/journal/article/fulltext/the-dilemma-of-tp53-codon-72-polymorphism-rs1042522-and-breast-cancer-risk-a-case-control-study-and-meta-analysis-in-iranian-population.pdfbreast cancergenetic variationpolymorphismtp53 |
| spellingShingle | Fahimeh Afzaljavan Negin Chaeichi Tehrani Mahdi Rivandi Saeed Zarif Ghasemian Elham Vahednia Reza Khayami Mohammad Abavisani Alireza Pasdar The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population Cell Journal breast cancer genetic variation polymorphism tp53 |
| title | The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population |
| title_full | The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population |
| title_fullStr | The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population |
| title_full_unstemmed | The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population |
| title_short | The Dilemma Of TP53 Codon 72 Polymorphism (Rs1042522) And Breast Cancer Risk: A Case-Control Study And Meta-Analysis In The Iranian Population |
| title_sort | dilemma of tp53 codon 72 polymorphism rs1042522 and breast cancer risk a case control study and meta analysis in the iranian population |
| topic | breast cancer genetic variation polymorphism tp53 |
| url | https://celljournal.org/journal/article/fulltext/the-dilemma-of-tp53-codon-72-polymorphism-rs1042522-and-breast-cancer-risk-a-case-control-study-and-meta-analysis-in-iranian-population.pdf |
| work_keys_str_mv | AT fahimehafzaljavan thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT neginchaeichitehrani thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT mahdirivandi thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT saeedzarifghasemian thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT elhamvahednia thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT rezakhayami thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT mohammadabavisani thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT alirezapasdar thedilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT fahimehafzaljavan dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT neginchaeichitehrani dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT mahdirivandi dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT saeedzarifghasemian dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT elhamvahednia dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT rezakhayami dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT mohammadabavisani dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation AT alirezapasdar dilemmaoftp53codon72polymorphismrs1042522andbreastcancerriskacasecontrolstudyandmetaanalysisintheiranianpopulation |